atai Life Sciences Announces Fourth Quarter and Full Year 2021 Financial Results, Reports on R&D Progress and… Mar 30, 2022
Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19 Mar 29, 2022
Cybin Announces Successful Completion of In Vivo Preclinical Studies for its Deuterated Psilocybin Analog CYB003… Mar 29, 2022
WonderFi Joins Canadian Web3 Council as Founding Member and Announces Appointment of Ameer Rosic as Independent Director Mar 29, 2022
Cybin-Sponsored Feasibility Study Using Kernel Flow Technology Currently Recruiting Participants Mar 24, 2022
COMPASS Pathways And Partners Launch The Centre For Mental Health Research And Innovation, In The UK Mar 24, 2022
